{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:28:37Z","timestamp":1761820117098,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016872","name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.prro.2021.04.006","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T08:41:53Z","timestamp":1621327313000},"page":"394-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-5018","authenticated-orcid":false,"given":"Divya","family":"Yerramilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela M.","family":"Alban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela L.","family":"Buscariollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin T.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Pretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2021.04.006_bib0001","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978\u20132013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2021.04.006_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0003","first-page":"97","article-title":"Paraaortic lymph node evaluation in stage I endometrial carcinoma","volume":"59","author":"Piver","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prro.2021.04.006_bib0004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0360-3016(93)90276-2","article-title":"Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus","volume":"26","author":"Hicks","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2021.04.006_bib0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): Final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: Results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2021.04.006_bib0008","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2021.04.006_bib0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): Final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"Powell","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.10.002","article-title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","volume":"132","author":"Kumar","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0011","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2021.04.006_bib0012","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2015.07.096","article-title":"Management of nodal recurrences of endometrial cancer with IMRT","volume":"139","author":"Ho","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0013","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.prro.2012.03.013","article-title":"Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer","volume":"3","author":"Shirvani","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0014","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2005.10.018","article-title":"Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: Technique and analysis of outcomes","volume":"101","author":"Dowdy","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2021.04.006_bib0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/COC.0000000000000318","article-title":"ACR appropriateness criteria\u00ae management of recurrent endometrial cancer","volume":"39","author":"Elshaikh","year":"2016","journal-title":"Am J Clin Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850021001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850021001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:24:12Z","timestamp":1761819852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850021001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1879850021001211"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2021.04.006","relation":{},"ISSN":["1879-8500"],"issn-type":[{"type":"print","value":"1879-8500"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2021.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}